Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate
نویسندگان
چکیده
منابع مشابه
Inhaled and intranasal fluticasone propionate and haematoma
Fluticasone propionate is a locally acting potent corticosteroid and is registered in the Netherlands since November 1990. It is marketed as nasal drops and nasal spray (Flixonase) for the indications vasomotor and allergic rhinitis, nasal polyps, and as inhalation corticosteroid (ICS) (Flixotide) in both an inhalation dosisaerosol and a powder inhalation form for indications asthma and chronic...
متن کاملEfficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis.
BACKGROUND Allergic rhinitis (AR) is an inflammatory condition of the nasal mucosa characterized by symptoms of nasal discharge, itching, sneezing, and congestion. Ocular symptoms are commonly associated with AR and include itching or burning, tearing or watering, and redness. Intranasal corticosteroids are a mainstay of treatment, and their effect on nasal symptoms is well described. OBJECTI...
متن کاملIntranasal triamcinolone and growth velocity.
BACKGROUND Inadequate designs and conflicting results from previous studies prompted the US Food and Drug Administration to publish guidelines for the design of clinical trials evaluating the effects of orally inhaled and intranasal corticosteroids on the growth of children. This study conformed to these guidelines to evaluate the effect of triamcinolone acetonide aqueous nasal spray (TAA-AQ) o...
متن کاملIntranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents
PURPOSE Our objective was to highlight the importance of database selection in observational research and to determine the incidence of corticosteroid-related events in patients exposed to fluticasone propionate intranasal spray (FPNS) compared with other intranasal steroids (INS). METHODS After a feasibility study using an electronic medical record database in the UK (1990-2002), a retrospec...
متن کاملIntranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
Intranasal and inhaled corticosteroid administration concurrently in comorbid allergic rhinitis (AR) and asthma may potentially enhance cortisol suppression. This study determined whether intranasal ciclesonide 200 micro g once daily has an additional effect on cortisol suppression when coadministered with inhaled fluticasone propionate-salmeterol (FP-SAL) 500 to 50 micro g twice daily. Adults ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Allergy, Asthma & Immunology
سال: 2020
ISSN: 1081-1206
DOI: 10.1016/j.anai.2020.01.012